CTLA-4 regulates tolerance induction and T cell differentiation in vivo - PubMed (original) (raw)

. 1998 Apr 15;160(8):3855-60.

Affiliations

• PMID: 9558090

CTLA-4 regulates tolerance induction and T cell differentiation in vivo

T L Walunas et al. J Immunol. 1998.

Abstract

Cytotoxic T lymphocyte Ag-4 (CTLA-4; CD152) is an important T cell regulatory molecule. In vitro experiments have shown that the blockade of signals through CTLA-4 augments T cell expansion, while CTLA-4 cross-linking results in decreased T cell proliferation due to decreased IL-2 production. However, less is known about the role of CTLA-4 in regulating an ongoing immune response. In this study, we examined the role of CTLA-4 in the expansion, decline, tolerization, and differentiation of T cells following treatment with staphylococcal enterotoxin B (SEB). Anti-CTLA-4 treatment resulted in increased numbers of SEB-reactive T cells and blockade of subsequent tolerance induction. Further examination of the SEB-reactive cells from anti-CTLA-4-treated mice demonstrated that both the CD4+ and CD8+ Vbeta8+ T cells produced IL-4, providing evidence that not only do signals through CTLA-4 regulate T cell-tolerizing events, but they also play an important role in the differentiation of T cells in vivo.

PubMed Disclaimer

Similar articles

• The role of CTLA-4 in regulating Th2 differentiation.
  Oosterwegel MA, Mandelbrot DA, Boyd SD, Lorsbach RB, Jarrett DY, Abbas AK, Sharpe AH. Oosterwegel MA, et al. J Immunol. 1999 Sep 1;163(5):2634-9. J Immunol. 1999. PMID: 10453003
• CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
  Merlo A, Saverino D, Tenca C, Grossi CE, Bruno S, Ciccone E. Merlo A, et al. Infect Immun. 2001 Oct;69(10):6022-9. doi: 10.1128/IAI.69.10.6022-6029.2001. Infect Immun. 2001. PMID: 11553539 Free PMC article.
• Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
  Kosmaczewska A, Ciszak L, Boćko D, Frydecka I. Kosmaczewska A, et al. Arch Immunol Ther Exp (Warsz). 2001;49(1):39-46. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11266089 Review.
• CTLA-4 and T cell activation.
  Oosterwegel MA, Greenwald RJ, Mandelbrot DA, Lorsbach RB, Sharpe AH. Oosterwegel MA, et al. Curr Opin Immunol. 1999 Jun;11(3):294-300. doi: 10.1016/s0952-7915(99)80047-8. Curr Opin Immunol. 1999. PMID: 10375557 Review.

Cited by

• Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases.
  D'Arena G, Rossi G, Vannata B, Deaglio S, Mansueto G, D'Auria F, Statuto T, Simeon V, De Martino L, Marandino A, Del Poeta8 G, De Feo V, Musto P. D'Arena G, et al. Mediterr J Hematol Infect Dis. 2012;4(1):e2012053. doi: 10.4084/MJHID.2012.053. Epub 2012 Aug 9. Mediterr J Hematol Infect Dis. 2012. PMID: 22973497 Free PMC article.
• Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity.
  Homann D, Dummer W, Wolfe T, Rodrigo E, Theofilopoulos AN, Oldstone MB, von Herrath MG. Homann D, et al. J Virol. 2006 Jan;80(1):270-80. doi: 10.1128/JVI.80.1.270-280.2006. J Virol. 2006. PMID: 16352552 Free PMC article.
• MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.
  Zitzer NC, Snyder K, Meng X, Taylor PA, Efebera YA, Devine SM, Blazar BR, Garzon R, Ranganathan P. Zitzer NC, et al. J Immunol. 2018 Jun 15;200(12):4170-4179. doi: 10.4049/jimmunol.1701465. Epub 2018 May 2. J Immunol. 2018. PMID: 29720426 Free PMC article.
• Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells.
  Kuhns MS, Epshteyn V, Sobel RA, Allison JP. Kuhns MS, et al. Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12711-6. doi: 10.1073/pnas.220423597. Proc Natl Acad Sci U S A. 2000. PMID: 11050166 Free PMC article.
• A bispecific protein capable of engaging CTLA-4 and MHCII protects non-obese diabetic mice from autoimmune diabetes.
  Zhao H, Karman J, Jiang JL, Zhang J, Gumlaw N, Lydon J, Zhou Q, Qiu H, Jiang C, Cheng SH, Zhu Y. Zhao H, et al. PLoS One. 2013 May 21;8(5):e63530. doi: 10.1371/journal.pone.0063530. Print 2013. PLoS One. 2013. PMID: 23704916 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program